lovastatin has been researched along with Airflow Obstruction, Chronic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gui, FF; Huo, XL; Jin, L; Min, JJ; Pan, CY; Pan, LL; Wang, XT; Zhao, CC | 1 |
Borges, VM; Bowler, RP; Fessler, MB; Henson, PM; Janssen, WJ; Kench, JA; McPhillips, KA; Morimoto, K; Vandivier, RW; Xiao, YQ | 1 |
2 other study(ies) available for lovastatin and Airflow Obstruction, Chronic
Article | Year |
---|---|
Efficacy of lovastatin on learning and memory deficits caused by chronic intermittent hypoxia-hypercapnia: through regulation of NR2B-containing NMDA receptor-ERK pathway.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Chronic Disease; Disease Models, Animal; Excitatory Amino Acid Antagonists; Gene Expression Regulation; GTPase-Activating Proteins; Hippocampus; Hypercapnia; Hypoxia; Learning Disabilities; Lovastatin; Male; MAP Kinase Signaling System; Maze Learning; Membrane Microdomains; Memory Disorders; Neuropeptides; Nootropic Agents; Piperidines; Pulmonary Disease, Chronic Obstructive; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Spatial Learning; Synaptosomes | 2014 |
Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease.
Topics: Animals; Apoptosis; CD36 Antigens; Cells, Cultured; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Jurkat Cells; Lovastatin; Lung; Lysophospholipids; Macrophages; Macrophages, Alveolar; Membrane Proteins; Mice; Mice, Inbred ICR; Monocytes; Phagocytosis; Protein Prenylation; Pulmonary Disease, Chronic Obstructive; rac1 GTP-Binding Protein; rhoA GTP-Binding Protein | 2006 |